Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 19 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Front face of vehicle wheel
Catalysts and process for producing aldehydes
Terminal for flat test probe
Powder for layerwise manufacturing of objects
Method and apparatus for closed-loop control of anti-tachyarrhythmia pacing using hemodynamic sensor
Method and apparatus for controlled reoxygenation
  Randomly Featured Patents
Composition, method and system for making high whiteness inkjet media
Capacitance-based proximity with interference rejection apparatus and methods
Method for distributing software based on software protection devices
Apparatus, and associated method, for communication system exhibiting time-varying communication conditions
Information processing apparatus, information processing method, and computer program for inputting insertion data to a data area of document data and sending output data processible by each o
Apparatus and method for providing and obtaining product information through a broadcast signal
Temperature stabilized stop-restart oscillator
Low voltage swing pad driver and receiver
Printhead, scanning type inkjet image forming apparatus having the same, and method of performing a printing operation with high resolution
Hybrid multiple quantum well spatial light modulator